TRT and Cardiovascular Risk

Introduction

The cleanest way to think about TRT and heart risk is this: testosterone replacement is not automatically dangerous, but it is not a wellness supplement. The relevant question is whether a particular man has confirmed testosterone deficiency, whether treatment makes sense for him, and whether therapy’s cardiovascular effects will be monitored.

The debate sharpened after the TRAVERSE trial, published in the New England Journal of Medicine in 2023. Among men with hypogonadism and preexisting or elevated cardiovascular risk, testosterone therapy was not inferior to placebo for major adverse cardiovascular events. That is reassuring. It is not a license to treat every symptom of aging with testosterone, nor does it eliminate the need for screening.

This guide separates the meaningful cardiovascular questions from internet shorthand. At TrimRx, our only program is physician-supervised GLP-1 weight loss. We do not prescribe TRT. We cover the subject because metabolic health, excess weight, blood pressure, and testosterone often overlap, making the treatment decision less straightforward.

At TrimRx, we believe understanding your options is the first step toward taking control of your health. If you want to see whether a personalized treatment plan is a fit for you, you can start with a quick online visit.

Does TRT Increase the Risk of a Heart Attack?

The strongest recent evidence does not show a higher rate of major cardiovascular events from prescribed testosterone in the population studied by TRAVERSE. The trial enrolled men with symptoms and laboratory-confirmed hypogonadism who also had existing cardiovascular disease or substantial cardiovascular risk. They received testosterone or placebo, and the primary cardiovascular outcome included cardiovascular death, nonfatal heart attack, and nonfatal stroke.

Quick Answer: The best current evidence does not show that properly prescribed testosterone replacement therapy increases major cardiovascular events in appropriately selected men, but it does not make TRT risk-free.

Testosterone was not inferior to placebo for that composite outcome. Put plainly, the trial did not find testosterone worse than placebo for the major cardiovascular events it was designed to measure.

That conclusion has limits. TRAVERSE studied men who met criteria for hypogonadism and received treatment under a clinical protocol. It did not show that testosterone improves heart health. It did not justify taking testosterone when levels are normal. It also does not establish that every formulation, dose, patient, or online protocol has the same risk profile.

Two popular claims should be rejected. “Testosterone causes heart attacks” is too sweeping. “Testosterone protects the heart” is equally unsupported. The defensible conclusion is narrower: in appropriately diagnosed men at elevated cardiovascular risk, properly monitored TRT did not increase the trial’s primary major cardiovascular outcome compared with placebo.

What Did the TRAVERSE Trial Actually Show?

TRAVERSE addressed a question earlier testosterone studies had left unresolved: does testosterone raise the risk of major cardiovascular events in men who have a legitimate reason for treatment and already carry cardiovascular risk?

Participants had hypogonadism, meaning low testosterone alongside relevant symptoms or clinical findings, and increased cardiovascular risk. The study compared testosterone gel with placebo gel. Treatment was monitored. This was not an open-ended bodybuilding or performance regimen.

The primary result was reassuring. Testosterone did not meet the threshold for being worse than placebo for major adverse cardiovascular events.

The trial also reported higher rates of atrial fibrillation, acute kidney injury, and pulmonary embolism in the testosterone group. That does not mean TRT inevitably causes those problems. It does mean that a reassuring heart attack result is not the same as a clean bill of health for every cardiovascular or clot-related concern.

In practice, the headline is only the beginning. A provider should review rhythm history, clotting history, kidney health, blood pressure, hematocrit, and current medications.

Why Does Testosterone Affect Cardiovascular Risk in the First Place?

Testosterone affects several systems relevant to cardiovascular health. One important effect is increased red blood cell production. If hematocrit climbs too high, blood becomes more concentrated. That creates a safety concern and may require dose adjustment, a treatment pause, or further evaluation.

Testosterone can also raise blood pressure. FDA-approved product labeling includes blood-pressure warnings, and a sustained increase matters because hypertension is itself a major cardiovascular risk factor. Starting TRT with uncontrolled blood pressure means starting with an avoidable problem already in the room.

Sleep, breathing, fluid balance, and the reason testosterone is low also matter. A man with untreated obstructive sleep apnea, significant obesity, diabetes, or established vascular disease may need those issues addressed as part of the same plan. Testosterone should not be treated as an isolated prescription.

This does not make testosterone uniquely hazardous. It makes it a medication with real physiologic effects that can alter important clinical markers. Good TRT requires active management. The prescription is not the end of the process.

Who Should Be Cautious About TRT and Heart Risk?

Men with recent cardiovascular events, uncontrolled high blood pressure, a history of blood clots, significant heart failure, untreated sleep apnea, or high hematocrit deserve particular caution. The final decision is individual, but none of these details belongs in the fine print.

A history of atrial fibrillation or another significant rhythm problem also needs direct discussion. TRAVERSE reported more atrial fibrillation in the testosterone group. A prior rhythm disorder is not a minor footnote.

The same is true of pulmonary embolism and other venous thromboembolism. A personal clotting history, a known clotting tendency, or unexplained prior events changes the risk discussion. The prescribing clinician needs to know about it before treatment begins.

Timing matters. After a recent heart attack, stroke, or other acute cardiovascular event, the question of whether and when to use TRT should be handled with appropriate medical supervision. The goal is not a permanent ban on testosterone. It is avoiding a new hormone treatment while an unstable cardiovascular problem is still being managed.

Does TRT Raise Blood Pressure?

It can. Testosterone products carry blood-pressure warnings, so blood pressure should be checked before treatment and during follow-up. That matters most when readings are already high or hypertension is not controlled.

One reading is not the whole story. A trend is. Home readings can help distinguish an isolated office measurement from sustained hypertension. If blood pressure rises after starting or increasing TRT, the provider may need to revisit the dose, the treatment itself, other medications, sodium intake, sleep, alcohol use, and the broader cardiovascular plan.

This is also why “natural testosterone optimization” marketing can mislead. Testosterone is a hormone with systemic effects. The body responds to the medication whether it comes through a clinic, an online program, or a pharmacy.

Men should be cautious about combining TRT with unreviewed supplements or performance products. The concern is not only testosterone. It is the uncertainty around what else is being taken, how those substances affect blood pressure, and whether anyone is monitoring the combined effect.

Why Does Hematocrit Matter During TRT?

Hematocrit is the proportion of blood made up of red blood cells. Testosterone can stimulate red blood cell production, making a rising hematocrit one of the clearest laboratory safety concerns associated with TRT.

A clinician should know the baseline hematocrit before treatment. Follow-up testing shows whether the level is moving in a concerning direction. Continuing the same dose without investigating a significant rise is not a sound plan.

Possible responses include lowering the dose, pausing treatment, changing the formulation, or investigating other contributors. Sleep apnea, smoking, lung disease, and living at high altitude can also affect red blood cell levels. The result needs interpretation, not an automatic reaction to a single number.

This is a practical dividing line between medically supervised TRT and casual hormone use. A responsible plan includes a baseline, a monitoring schedule, and a defined response when the numbers change.

Key Takeaway: Testosterone can raise blood pressure and increase red blood cell production, which is why blood pressure and hematocrit belong in routine monitoring.

Is TRT Safe for Men with Existing Heart Disease?

Not automatically no. TRAVERSE included men with existing or elevated cardiovascular risk, and its primary result was reassuring for major adverse cardiovascular events. That evidence is relevant to men who genuinely have hypogonadism and are being considered for treatment.

Existing heart disease still makes individualized assessment more important. A clinician needs to understand the type and stability of the heart condition, current blood pressure, rhythm history, clot risk, kidney function, medications, and treatment goals.

TRT should not be presented as a treatment for heart disease. Its purpose is to address documented testosterone deficiency when the expected benefits justify the risks and monitoring burden. Low energy, reduced sexual desire, erectile problems, and loss of strength can have many causes. Cardiovascular disease, poor sleep, depression, medication effects, diabetes, and excess weight may all contribute.

The careful approach is neither automatic avoidance nor automatic prescribing. It is diagnosis first, risk review second, and monitoring throughout.

Does Low Testosterone Itself Increase Cardiovascular Risk?

Low testosterone and cardiovascular risk often occur together. That association does not prove that low testosterone alone causes heart disease, and it does not show that testosterone replacement prevents heart disease. Men with obesity, diabetes, sleep apnea, and other metabolic conditions may have lower testosterone as part of a broader health problem.

A low laboratory value should therefore not stand alone. The Endocrine Society recommends diagnosing hypogonadism in men with compatible symptoms and consistently low testosterone concentrations, confirmed with appropriate testing. Context is not optional.

A man with one borderline result and vague fatigue may need a broader evaluation instead of an immediate prescription. Sleep, medications, alcohol, mental health, recent illness, weight change, and metabolic disease can all affect both symptoms and testosterone levels.

TRT may be appropriate when the diagnosis is solid. It is not a shortcut around finding the cause.

Can Weight and Metabolic Health Change the TRT Conversation?

Yes. Excess weight and metabolic dysfunction are common among men evaluated for low testosterone. They can also produce symptoms often blamed on hormones alone. Poor sleep, insulin resistance, high blood pressure, and low fitness can all contribute to fatigue and sexual difficulties.

Weight loss and better metabolic health can clarify the picture. If symptoms improve as sleep, activity, blood pressure, and weight improve, the treatment need may differ from that of a man with persistent symptoms and repeatedly low testosterone despite addressing those factors.

That does not mean every man should lose weight first and ignore a genuine hormone deficiency. It means both issues should be evaluated together. Treating the hormone while leaving major metabolic drivers untouched may deliver a partial answer.

At TrimRx, our focus is GLP-1 weight loss under medical supervision. We do not treat testosterone deficiency or cardiovascular disease. For men whose low energy, blood pressure, sexual symptoms, and excess weight are intertwined, a weight and metabolic assessment can be a useful part of the larger conversation with a qualified clinician.

What Should Be Monitored During TRT?

A safe TRT plan begins by confirming the diagnosis and reviewing cardiovascular history. Baseline information commonly includes testosterone testing, a complete blood count with hematocrit, blood pressure, and a review of relevant conditions and medications. Depending on age, symptoms, and clinical risk, prostate evaluation and monitoring may also be appropriate.

Follow-up is part of the treatment, not an optional add-on. The provider should reassess symptoms, testosterone levels, hematocrit, blood pressure, and adverse effects after treatment starts and after meaningful dose changes. The precise schedule depends on the formulation and the patient.

Report possible cardiovascular or clot-related symptoms promptly. Chest pain, severe shortness of breath, fainting, sudden neurologic symptoms, or one-sided leg swelling require urgent medical attention. New palpitations or a persistently irregular heartbeat also warrant evaluation.

A useful TRT visit should tell you what will be measured, when it will be checked, and what would cause treatment to change. Without those details, the plan is incomplete.

The Path Forward

The current answer to TRT and cardiovascular risk is more precise than the old headlines. In men with confirmed hypogonadism and elevated cardiovascular risk, TRAVERSE did not find testosterone worse than placebo for major cardiovascular events. Testosterone can still raise blood pressure and hematocrit, and the trial reported more atrial fibrillation, acute kidney injury, and pulmonary embolism in the treatment group. Diagnosis and monitoring remain essential.

TrimRx is a GLP-1 weight loss telehealth program, not a TRT or heart-care clinic. If excess weight and metabolic health are part of your broader picture, our free assessment quiz is a straightforward way to see whether medically supervised weight loss may fit. Take the results to your clinician along with your testosterone questions. The safest hormone decision is the one made with the entire cardiovascular picture in view.

Bottom line: Cardiovascular risk depends on the whole picture: blood pressure, cholesterol, diabetes, smoking, sleep, weight, prior heart disease, and the reason TRT is being considered.

FAQ

Does TRT Cause Heart Attacks?

Current evidence does not show an increased risk of major cardiovascular events from appropriately prescribed TRT in the men studied in the TRAVERSE trial. Those men had confirmed hypogonadism and elevated cardiovascular risk. TRT is still not risk-free and should not be used without a clear diagnosis and follow-up monitoring.

What Did the TRAVERSE Trial Find?

TRAVERSE found that testosterone therapy was not inferior to placebo for major adverse cardiovascular events in men with hypogonadism and existing or elevated cardiovascular risk. The trial also reported higher rates of some other adverse events, including atrial fibrillation, acute kidney injury, and pulmonary embolism in the testosterone group.

Can Testosterone Raise Blood Pressure?

Yes. Testosterone products carry blood-pressure warnings, and blood pressure should be checked before and during treatment. A sustained rise may require changes to the TRT dose or a broader review of cardiovascular health and other contributing factors.

Why Is Hematocrit Monitored During TRT?

Testosterone can increase red blood cell production. Hematocrit testing helps identify when the blood count is rising too high, which can create a safety concern. Baseline and follow-up testing are important parts of responsible TRT management.

Is TRT Safe If I Have Heart Disease?

Existing heart disease does not automatically rule out TRT, and men with cardiovascular risk were included in TRAVERSE. The decision should account for the type and stability of the heart condition, blood pressure, rhythm history, clot risk, medications, and whether testosterone deficiency has been properly confirmed.

Should Men with a History of Blood Clots Avoid TRT?

A history of pulmonary embolism, deep vein thrombosis, or another clotting problem requires careful review before TRT. Testosterone can affect red blood cell production, and TRAVERSE reported more pulmonary embolism in the testosterone group. Do not begin treatment without discussing the full history with the prescribing clinician.

Can Losing Weight Improve Low-testosterone Symptoms?

Weight and metabolic health can contribute to fatigue, poor sleep, sexual symptoms, and lower testosterone levels. Improving those factors may clarify whether testosterone deficiency is the main problem, though it does not replace evaluation when laboratory results and symptoms consistently support hypogonadism.

Does TrimRx Prescribe Testosterone?

No. TrimRx provides physician-supervised GLP-1 weight loss and does not prescribe TRT. Its role is to help adults evaluate whether a medically supervised weight-loss program may fit, while testosterone and cardiovascular questions should be handled with a qualified clinician.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any treatment or medication.